Rong Chu
Overview
Explore the profile of Rong Chu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1881
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang X, Chu B, Ding C, Li Z, Ding H, Chu R, et al.
Zhongguo Zhong Yao Za Zhi
. 2024 Dec;
49(19):5365-5381.
PMID: 39701775
The investigation of new strategies to prevent acute viral respiratory infections(ARI) is essential for reducing the global disease burden. Genetic association studies are valuable in identifying the susceptibility risk factors...
2.
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L, et al.
BMC Med Res Methodol
. 2023 Mar;
23(1):59.
PMID: 36927764
No abstract available.
3.
Joshi N, Fine J, Chu R, Ivanova A
J Biopharm Stat
. 2019 Jul;
29(4):685-695.
PMID: 31269870
We consider the problem of estimating a biomarker-based subgroup and testing for treatment effect in the overall population and in the subgroup after the trial. We define the best subgroup...
4.
McHugh D, Eisenberger M, Heath E, Bruce J, Danila D, Rathkopf D, et al.
Invest New Drugs
. 2019 Feb;
37(5):1052-1060.
PMID: 30725389
Background Antibody drug conjugates (ADC) offer the potential of maximizing efficacy while minimizing systemic toxicity. ASG-5ME, an SLC44A4-targeting antibody carrying monomethyl auristatin E (MMAE), a microtubule-disrupting agent, was investigated in...
5.
Chu R, Alford S, Hart K, Kothari A, Mackintosh S, Kovak M, et al.
Oncotarget
. 2016 Oct;
7(48):78958-78970.
PMID: 27738316
Microtubule targeting agents (MTAs) characteristically promote phosphorylation and degradation of Mcl-1, and this represents a critical pro-apoptotic signal in mitotic death. While several phosphorylation sites and kinases have been implicated...
6.
Reitsma A, Chu R, Thorpe J, McDonald S, Thabane L, Hutton E
Trials
. 2014 Sep;
15:377.
PMID: 25257928
Background: Clustering of outcomes at centers involved in multicenter trials is a type of center effect. The Consolidated Standards of Reporting Trials Statement recommends that multicenter randomized controlled trials (RCTs)...
7.
Huang J, Liu G, Zhang Y, Cui Z, Wang F, Liu X, et al.
BMC Med
. 2014 Jun;
12:81.
PMID: 24884842
Background: Focal segmental glomerulosclerosis (FSGS) is a major cause of end-stage renal disease. Recent studies have proposed that plasma soluble urokinase receptor (suPAR) might be a causative circulating factor but...
8.
Chu R, Li C, Wang S, Zou W, Liu G, Yang L
Clin J Am Soc Nephrol
. 2014 May;
9(7):1175-82.
PMID: 24789552
Background And Objectives: AKI is a clinical syndrome with various causes involving glomerular, interstitial, tubular, and vascular compartments of the kidney. Acute kidney disease (AKD) is a new concept that...
9.
Li C, Su T, Chu R, Li X, Yang L
Clin J Am Soc Nephrol
. 2013 Nov;
9(1):21-8.
PMID: 24202135
Background And Objectives: Tubulointerstitial nephritis and uveitis (TINU) syndrome is considered a rare cause of acute tubulointerstitial nephritis (ATIN) that is usually associated with renal recovery. This study sought to...
10.
Rodseth R, Biccard B, Le Manach Y, Sessler D, Lurati Buse G, Thabane L, et al.
J Am Coll Cardiol
. 2013 Oct;
63(2):170-80.
PMID: 24076282
Objectives: The objective of this study was to determine whether measuring post-operative B-type natriuretic peptides (NPs) (i.e., B-type natriuretic peptide [BNP] and N-terminal fragment of proBNP [NT-proBNP]) enhances risk stratification...